2021 Postgraduate Course - Part I, II and III: Managing the Epidemic of Fatty Liver from Obesity and Alcohol

Product not yet rated

Recorded On: 11/11/2021

Nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease are two principal causes of advanced liver disease in the U.S., and both contribute heavily to rising incidence of hepatocellular carcinoma. Faculty will identify drivers of disease progression in both diseases, provide guidance on optimal management strategies, and discuss emerging therapeutic options most likely to be in the future treatment armamentarium.

Key:

Complete
Failed
Available
Locked
Part I: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
Open to view video.
Open to view video.
Part II: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
Open to view video.
Open to view video.
Part III: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
Open to view video.
Open to view video.
Live Q&A: Managing the Epidemic of Fatty Liver from Obesity and Alcohol
Open to view video.
Open to view video.
Final Evaluation
Final Evaluation
7 Questions